BOSTON, Aug. 9, 2021 /PRNewswire/ -- Haemonetics
Corporation (NYSE: HAE), a global medical technology company
focused on delivering innovative medical solutions to drive better
patient outcomes, announced the election of Lloyd E.
Johnson to its Board of Directors. In addition, the company
announced that Ellen Zane will serve
as the new independent Chair of Haemonetics' Board of
Directors.
Johnson served as Global Managing Director, Finance and Internal
Audit at Accenture Corporation from 2004 until his retirement in
2015, where he led the global management consulting company's audit
organization and provided strategic leadership in finance, risk,
compliance and governance. Prior to joining Accenture, Johnson
served as Executive Director, M&A and General Auditor for
Delphi Automotive PLC, a global automotive technology industry
leader. He has also held senior financial leadership positions at
Emerson Electric Corporation, Sara Lee Corporation and Shaw Food
Services. Johnson currently serves on the boards of Apogee
Enterprises, Inc.; Beazer Homes USA, Inc.; AARP, where he is second Vice
Chair; and the NACD Carolinas Chapter.
"With over 35 years of senior finance leadership experience,
Lloyd brings significant expertise and strategic insight to the
Board in the areas of accounting and financial management, mergers
and acquisitions, international operations, business development,
corporate governance and enterprise risk management," said
Ellen Zane, Chair of Haemonetics'
Board of Directors. "We look forward to welcoming him to our Board
of Directors as Haemonetics pursues its strategies to deliver
shareholder value."
Johnson earned his bachelor's and master's degrees from the
University of South Carolina and a
Master of Business Administration from Duke
University. He was named one of the "Most Influential Black
Corporate Directors" by Savoy in 2017 and has been listed as
a "Director to Watch" in 2018 and 2020 by Directors &
Boards.
Zane succeeds Richard Meelia, who
retired as Board Chairman and a director effective as of
Haemonetics' 2021 Annual Meeting of Shareholders on August 6, 2021. "Ellen is a nationally renowned
healthcare leader and has been an invaluable member of the
Haemonetics Board, including her service as Chair of the Governance
and Compliance Committee," said Mr. Meelia. "She has my full
support and confidence as the new Chair of the Board of Directors."
Zane rejoined Haemonetics' Board of Directors in 2018 after
previously serving on the company's Board from 2012-2016.
About Haemonetics
Haemonetics (NYSE: HAE) is
a global healthcare company dedicated to providing a suite of
innovative medical products and solutions for customers, to help
them improve patient care and reduce the cost of healthcare. Our
technology addresses important medical markets: blood and plasma
component collection, the surgical suite and hospital transfusion
services. To learn more about Haemonetics,
visit www.haemonetics.com.
Investor
Contact:
Olga Guyette,
Director-Investor Relations
(781)
356-9763
olga.guyette@haemonetics.com
|
|
Media
Contact:
Josh Gitelson,
Director-Global Communications
(781)
356-9776
josh.gitelson@haemonetics.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lloyd-e-johnson-joins-haemonetics-board-of-directors-ellen-zane-announced-as-new-board-chair-301350979.html
SOURCE Haemonetics Corporation